SULT1A1 and breast carcinoma: We used random-effect model (Heterogeneity chi-squared = 31.11 (d.f. = 14) I-squared = 55.0%, P = 0.005) to analyze Arg/Arg vs Arg/His (OR = 1.06, 95%CI: 0.95-1.18, P = 0.291) (Fig. 1) and fixed-effect model (Heterogeneity chi-squared = 15.21 (d.f. = 12) I-squared = 21.1%, P = 0.230) to analyze Arg/Arg vs His/His (OR = 1.07, 95%CI: 0.97-1.18, P = 0.197) (Fig. 2), there was no relationship between SULT1A1 and breast cancer risk either.